Anti-anxiety Biotics for Breast Cancer Survivors
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Anxiety Generalized
- Breast Cancer - Female
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Placebo controlled randomized controlled trialMasking: Triple (Participant, Investigator, Outcomes Assessor)Masking Description: One study staff member will be responsible for randomization and allocation of intervention supplement or placebo, which will be appear to be identicalPrimary Purpose: Supportive Care
Participation Requirements
- Age
- Between 50 years and 75 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04784182
- Collaborators
- University of Alabama at Birmingham - Center for Clinical and Translational Science
- Investigators
- Principal Investigator: Andrew D Frugé, PhD Auburn University